The influence of apigenin on cellular responses to radiation: From protection to sensitization

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Taha Monadi, Zahra Mohajer, Afsaneh Soltani, Mohammad Amin Khazeei Tabari, Azadeh Manayi, Mohammad Azadbakht
Formato: Artículo Open Access
Publicado: Wiley 2024
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867013657501630464
author Taha Monadi
Zahra Mohajer
Afsaneh Soltani
Mohammad Amin Khazeei Tabari
Azadeh Manayi
Mohammad Azadbakht
author_facet Taha Monadi
Zahra Mohajer
Afsaneh Soltani
Mohammad Amin Khazeei Tabari
Azadeh Manayi
Mohammad Azadbakht
Taha Monadi
Zahra Mohajer
Afsaneh Soltani
Mohammad Amin Khazeei Tabari
Azadeh Manayi
Mohammad Azadbakht
collection Wiley Open Access
contents The influence of apigenin on cellular responses to radiation: From protection to sensitization Taha Monadi Zahra Mohajer Afsaneh Soltani Mohammad Amin Khazeei Tabari Azadeh Manayi Mohammad Azadbakht BioFactors Abstract Apigenin, a dietary flavonoid, has gained increasing attention for its potential therapeutic applications in radiation protection and radiosensitization. Ionizing radiation (IR) can harm healthy cells, but as radiotherapy remains crucial in cancer treatment. Owing to the remarkable application of radiotherapy in the treatment of cancers, it is vital to protect healthy cells from radiation hazards while increasing the sensitivity of cancer cells to radiation. This article reviews the current understanding of apigenin's radioprotective and radiosensitive properties with a focuses on the involved signaling pathways and key molecular targets. When exposed to irradiation, apigenin reduces inflammation via cyclooxygenase‐2 inhibition and modulates proapoptotic and antiapoptotic biomarkers. Apigenin's radical scavenging abilities and antioxidant enhancement mitigate oxidative DNA damage. It inhibits radiation‐induced mammalian target of rapamycin activation, vascular endothelial growth factor (VEGF), matrix metalloproteinase‐2 (MMP), and STAT3 expression, while promoting AMPK, autophagy, and apoptosis, suggesting potential in cancer prevention. As a radiosensitizer, apigenin inhibits tumor growth by inducing apoptosis, suppressing VEGF‐C, tumor necrosis factor alpha, and STAT3, reducing MMP‐2/9 activity, and inhibiting cancer cell glucose uptake. Cellular and animal studies support apigenin's radioprotective and anticancer potential, making it a potential candidate for further research. Investigation into apigenin's therapeutic efficacy in diverse cancer types and radiation damage is essential. 10.1002/biof.2113 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/biof.2113
format Artículo Open Access
id wiley_oa_10_1002_biof_2113
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle The influence of apigenin on cellular responses to radiation: From protection to sensitization
Taha Monadi
Zahra Mohajer
Afsaneh Soltani
Mohammad Amin Khazeei Tabari
Azadeh Manayi
Mohammad Azadbakht
BioFactors
The influence of apigenin on cellular responses to radiation: From protection to sensitization Taha Monadi Zahra Mohajer Afsaneh Soltani Mohammad Amin Khazeei Tabari Azadeh Manayi Mohammad Azadbakht BioFactors Abstract Apigenin, a dietary flavonoid, has gained increasing attention for its potential therapeutic applications in radiation protection and radiosensitization. Ionizing radiation (IR) can harm healthy cells, but as radiotherapy remains crucial in cancer treatment. Owing to the remarkable application of radiotherapy in the treatment of cancers, it is vital to protect healthy cells from radiation hazards while increasing the sensitivity of cancer cells to radiation. This article reviews the current understanding of apigenin's radioprotective and radiosensitive properties with a focuses on the involved signaling pathways and key molecular targets. When exposed to irradiation, apigenin reduces inflammation via cyclooxygenase‐2 inhibition and modulates proapoptotic and antiapoptotic biomarkers. Apigenin's radical scavenging abilities and antioxidant enhancement mitigate oxidative DNA damage. It inhibits radiation‐induced mammalian target of rapamycin activation, vascular endothelial growth factor (VEGF), matrix metalloproteinase‐2 (MMP), and STAT3 expression, while promoting AMPK, autophagy, and apoptosis, suggesting potential in cancer prevention. As a radiosensitizer, apigenin inhibits tumor growth by inducing apoptosis, suppressing VEGF‐C, tumor necrosis factor alpha, and STAT3, reducing MMP‐2/9 activity, and inhibiting cancer cell glucose uptake. Cellular and animal studies support apigenin's radioprotective and anticancer potential, making it a potential candidate for further research. Investigation into apigenin's therapeutic efficacy in diverse cancer types and radiation damage is essential. 10.1002/biof.2113 http://onlinelibrary.wiley.com/termsAndConditions#vor
title The influence of apigenin on cellular responses to radiation: From protection to sensitization
topic BioFactors
url https://iubmb.onlinelibrary.wiley.com/doi/10.1002/biof.2113